Stem cells, DNA damage, ageing and cancer  by Pazhanisamy, Senthil Kumar
review
Hematol Oncol Stem Cell Ther 2(3)     Third Quarter 2009 hemoncstem.edmgr.com 375
Stem cells, DNA damage, ageing and cancer
pathology and laboratory medicine, school of medicine, medical university of south carolina, charleston, sc 29425, usa
corresppondence: senthil Kumar pazhanisamy · pathology and laboratory medicine, school of medicine, medical university of south carolina, 
charleston, sc 29425, usa · t: +1(843)792-4874 f: +1(843)792-0368 · senthilp@musc.edu, skp5@musc.edu
hematol oncol stem cell ther 2009: 2(3): 375-384
Senthil Kumar Pazhanisamy
a comprehensive knowledge of adult stem cells not only sheds light on their significant roles in many fun-
damental biological process, but also on their implications in a variety of deleterious disorders including 
leukemia, lymphoma, ageing and other relevant degenerative disorders. elucidating the diverse signaling 
pathways in stem cells paves the way for development of targeted therapeutic approaches against degen-
erative disorders. despite emerging studies, our understanding of the key molecular machineries that pro-
foundly influence key stem cell properties is poor. this review discusses the seminal aspects of stem cell 
self-renewal mechanisms with an emphasis on various influencing factors, including dna damage, and 
intrinsic and extrinsic factors that govern the significant characteristics of tissue stem cells under normal 
and stress conditions. also outlined are intriguing aspects of how molecular interventions in key stem cell 
pathways could be exploited to develop novel therapies against stem cell disorders.
Adult stem cells are a lifettime reservoir for varitous lineagetspecific cells and are responsible for remarkably preserving both tissue function 
and capability to respond against various stresses. Since 
mature blood cells are predominantly short lived, hemat
topoietic stem cells are required throughout the lifespan 
to replenish multitlineage progenitors and precursors 
committed to their hematopoietic lineages. Generally, 
adult stem cells are endowed with unique selftrenewal 
and differentiation abilities to generate their daughter 
stem cells and mature cell types, respectively. Recent 
evidence suggests that although primitive, longtterm 
reconstituting hematopoietic stem cells (LTtHSCs) 
remain relative quiescent. They can reversely and infret
quently switch into cell cycle to selftrenew or differentit
ate into multitlineage progenitor cells.1 In the hematot
poietic hierarchy system, LTtHSCs divide infrequently 
to supply more proliferative shorttterm HSCs, which in 
turn generate various multitpotent progenitors that as a 
consequence, give rise to more differentiated progenitor 
cells.2 Under homeostatic conditions, stem cells cont
tinuously selftrenew and differentiate with only limited 
proliferative potential so as to protect the hematopoietic 
cells from mutagenic insults, ageing and carcinogenesis. 
The striking balance among relativetquiescence, selft
renewal and multitlineage commitment is regulated by 
various intrinsic and extrinsic regulatory mechanisms 
(Figure 1).3 
Molecular features of self-renewal in stem cells
A defining characteristic of stem cells is their impressive 
selftrenewal potential with longtterm differentiation cat
pabilities. The fascinating aspect is that stem cells of the 
same tissue origin can show remarkable differences in 
their selftrenewal and cell cycle characteristics at differt
ent developmental stages. Embryonic stem cells (ESCs) 
derived from the inner cell mass of the early mammat
lian embryo have pluripotent potential, with the ability 
to differentiate into virtually all the cell types of an adult 
animal. In contrast to ESCs, adult stem cells possess 
only multipotent potential giving rise to differentiated 
and lineagetcommitted tissue cells. Although HSC are 
evolved from ESC, they migrate through different ort
gans during developmental stages with the specific purt
pose to replenish tissue maintenance and repair. In early 
embryogenesis (period of 11.5t16.5 embryonic days), 
HSCs are driven to the fetal liver for profound expant
sion and then eventually migrate to the bone marrow 
niche where they remain under relative quiescence, but 
infrequently undergo selftrenewal and a multipotent 
proliferation process.4 This demonstrates the adoptive 
nature of stem cells corresponding to their development
tal requirements. For instance, fetal HSCs were shown 
to have an intrinsic ability to selftrenew and differentit
ate, which was maintained until 1 week after birth. At 
this time, the HSCs switched to being quiescent, similar 
to adult HSCs. For instance, it is apparent that the selft
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renewal characteristics of stem cells remain active not 
only during early development, but also in adult stem 
cells for the purpose of development of mature organs.5,6 
Moreover, ESCs undergo symmetrical selftrenewal divit
sions, with one stem cell giving rise to two daughter stem 
cells, resulting in an expansion in stem cell numbers. In 
contrast, adult HSCs predominantly undergo asymt
metrical selftrenewal divisions, generating one stem cell 
and one more committed cell, thus preserving stem cell 
numbers while enabling blood cell regeneration in vivo.7 
HSC undergo symmetrical selftrenewal divisions only 
in specific and temporally restricted developmental cont
texts. ESCs lines could be maintained and expanded in 
vitro for a longer time period whereas adult HSCs have 
limited in vitro potential. Interestingly, the fate of ESC is 
more stringently regulated and less susceptible to quiest
cence and senescence than HSC. 
Stem cell functionalities are profoundly regulated 
by complex mechanisms arising from celltautonomous 
regulation, to their local and systemic milieu within the 
stem cell niche, the surrounding tissue, and the external 
environment. Alteration cues from any or a combination 
of these signals could influence the functionality and/or 
number of stem cells. Selftrenewal is activated by diverse 
signals, such as developmental regulators or certain ont
cogenes. Studies report that selftrenewal is linked to the 
cell cycle.6 The regenerative potential of stem cells is ret
stricted in such a fashion they can only replicate a defit
nite number of times during the lifespan of an organism, 
suggesting an intrinsic limitation of the stem cell. This 
intrinsic limitation is attained if stem cells are induced to 
proliferate rapidly due to environmental stresses such as 
radiotherapy or chemotherapy. 
Intrinsic mechanisms of self-renewal in stem cells
Although stem cells accrue DNA damage over the lifet
time of an organism, studies illustrate that both stem 
cell frequency and absolute numbers are not profoundly 
Figure 1. The physiological consequences of balance and imbalance self-renewal processes in stem cells (self-renewal represented 
by the counterclockwise arrow over the adult stem cell). (a): delicate balance between self-renewal and differentiation properly 
maintains the stem cell number with regular homeostasis, tissue function and tissue repair. (B): elevated self-renewal triggered by 
various factors initiate tumorigenesis with profound increase in stem cell numbers which leads to cancer formation. (C): impaired self-
renewal reduces the size of the stem cell pool and increases the stem cell differentiation thereby leading to tissue degeneration, stem 
cell exhaustion, and ageing phenotype.
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diminished under normal conditions.8 Similarly, their 
interaction with stroma is not diminished with age. 
However, interestingly, HSCs are less effective at homt
ing and engrafting, suggesting that intrinsic characterist
tic of HSCs could play a role in agetmediated attrition 
of HSCs functionalities as DNA damage accumulates. 
Most of the developmental pathways involved in selft
renewal are conserved in many tissues and in many ort
ganisms. Although key master regulators of adult HSC 
cell fate are still poorly defined, the molecular bases of 
ESC selftrenewal are more rapidly unfolding, with ret
cent evidence suggesting the involvement of distinct set 
of genes viz., Nanog/Oct4/Sox2 and Tbx3/Tcl1,9 in the 
regulation of separate pathways. Studies elucidate that 
Notch, Wnt and Hedgehogtmediated fundamental 
mechanisms commonly exhibit selftrenewal machinert
ies by either activating or repressing many target genes 
involved in diverse stem cells population from hemat
topoietic, neural tissue, skin, epithelium and germline 
tissues.6 Recent investigations suggest that several patht
ways exhibit a selftrenewal process.5 For instance, WNT 
proteins, Hedgehog proteins, bone morphogenetic prot
teins (BMPs) and the Notch stimulate the activation and 
translocation of transcription factors into the nucleus.3 
In this, Notch activation is critical to maintaining the 
selftrenewal of stem cells in diverse stem cell niches from 
the worm germ line to mammalian HSCs. One common 
mechanism by which stem cells maintain selftrenewal is 
inhibition of differentiation. This is apparent in both 
ESCs and tissue stem cells where Foxd3, the wingedthet
lix transcription factor is reported to suppress the differt
entiation and thereby maintain the selftrenewal in both 
pluripotent and multipotent stem cells.10t12 The selftret
newal process should be stringently used to correspond 
to tissue homeostatic demands. Continuous activation of 
the selftrenewal program can lead to stem cell exhaust
tion. For instance constitutively activated btcatenin leads 
to prominent defect in multilineage differentiation.13,14
Although some critical selftrenewal pathways comt
monly drive the downstream signaling machineries in 
most stem cells types, some pathways are unique to cert
tain tissues or under specific circumstances. Concerted 
and stringent regulation of multiple pathways tightly 
regulate the selftrenewal program in ES cells, which are 
unique to pluripotent cells. The molecular switches that 
govern global transcriptome machineries are differently 
regulated while transiting through various development
tal stages.15 For instance, Oct416 and Nanog17 are trant
scription factors required for pluripotency during early 
embryogenesis and for maintenance of ESC identity, but 
not essential for multipotentiality in somatic stem cells. 
Fetal HSCs require Sox18 for the maintenance whereas 
it is dispensable in adult HSCs. Conversely, Gfit1 and 
Et6 are essential for selftrenewal in adult HSCs but 
not in fetal HSCs. A recent study confirms that Zfx, a 
transcriptional regulator mediates selftrenewal in both 
embryonic and adult stem cells, suggesting a common 
mechanism for selftrenewal.18 Interestingly, deletion of 
Zfx impaired selftrenewal, but not the differentiation 
capacity of murine ESC; conversely, Zfx overexpression 
facilitated ESC selftrenewal by opposing differentiation. 
Furthermore, Zfx deletion abolished the maintenance of 
adult HSC, but did not affect erythromyeloid progenit
tors or fetal HSC.18 Taken together, these reports cont
firm that stem cells employ different mechanisms at varit
ous developmental stages to regulate the pluripotency as 
compared to multipotency irrespective of some shared 
molecular programs. 
As the selftrenewal process tightly couples with cell 
cycle regulatory pathways, cell cycle signaling cascades 
dictate selftrenewal and proliferation in tissue stem cells. 
Cyclin DtCDK4/6 plays a prominent role in entry into 
cell cycle by inactivating Rb proteins, the mediator of 
quiescence. Dtcyclins are essential for the expansion of 
hematopoietic stem cells by enhancing their selftrenewal 
and their absence is exemplified by stem cell depletion 
during fetal development,19 but they are dispensable in 
ES cells. Ink4 family proteins negatively regulate selft
renewal by downtregulating DtCDK4/6 complex and 
also reduce both the frequency and function of stem 
cells. Likewise other tumor suppressor machineries for 
instance, p19/p53/p21 pathway negatively regulates 
stem cell frequency. Depletion of these factors enhances 
stem cell frequency and functionality. For instance, Bmit
1, a repressor of p16Ink4a/19Arf promotes selftrenewal 
in the postnatal period. Deficiency of Bmit1 profoundly 
decreases selftrenewal and depletes the stem cell pool in 
various tissues.20 Collectively, these studies illustrate a 
tight regulation of selftrenewal machineries which prot
foundly maintain a perfect balance to meet the regent
erative demand throughout life, while avoiding extensive 
transformation into cancer (Figure 2).
Transcription driven self-renewal
Interestingly, the switch between selftrenewal and differt
entiation is also dictated by competitive actions of trant
scription factor complexes. For instance, the transcription 
factors, GATA1 and PU.1 mediate the erythroid and 
myeloid lineages, respectively. They inhibit each other’s 
ability to bind to the target genes such that if GATA1 
is deficient, PU.1 shifts the balance toward the myeloid 
program. Conversely, an absence or deficiency of PU.1 
leads GATA1 to drive erythroid program.21t23 Besides, 
competitive transplantation experiments suggest that 
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downtregulation of transcription factors GATA2, GFI1, 
myc and SMAD4 inhibit the selftrenewal characteristic 
of HSCs. The impact of the transcription pathways on 
stem cells is profound, such that a set of transcription 
factors including OCT4, SOX2, Myc and KLF4 could 
reprogram a fibroblast to induce a pluripotent stem 
(iPS) cell, demonstrating that transcription factors can 
induce pluripotency and selftrenewal.24 Mutation in this 
transcription machinery could disrupt the homeostatic 
balance to favor either selftrenewal or differentiation. 
Role of epigenetic mechanisms in self-renewal
New studies have implicated a role for epigenetic regut
lation in the selftrenewal of hematopoietic and neural 
stem cells. Interestingly, certain chromatintassociated 
factors could either silence or activate the gene exprest
sion of specific genes by histone modifications that in 
turn modulate the selftrenewal. This phenomenon could 
be best illustrated by epigenetic mechanisms of Bmit
1, a member of the Polycomb group (PcG), known for 
promoting selftrenewal. BMIt1 actively engaged in the 
selftrenewal program by regulating the transcription 
of celltcycle regulator INK4A (a negative regulator of 
CDK4tDttype cyclins).17 The defective selftrenewal 
of HSC has been attributed to derepression of p16Ink4a 
and p19Arf via Bmit1 targeted silencing mechanism and 
impaired selftrenewal, at least in part, could be reversed 
by downregulation of these target genes in Bmit1t/t stem 
cells. This accounts for why mice with Bmi1t/t mice post
sess impaired stem cell pool associated with progressive 
postnatal pancytopenia.25 BMI1 also shown to repress 
transcription factor E4F1 in haematopoietic stem cells 
epigenetically. Similarly, overexpression and inactivation 
of MLL, regulated by the Polycomb complex, lead to int
creased selftrenewal26 and deficient HSC selftrenewal27 
respectively. Epigenetic changes in stem cells are not 
permanent and can be erased (partly or completely) by 
cell division. Therefore, such changes might facilitate the 
transition of a progenitor cell to a selftrenewing stem cell, 
or prompt differentiation with diminished selftrenewal 
Figure 2. regulators involved in self-renewal processes in stem cells. Stem cell self-renewal is activated by diverse signals such 
as developmental regulators, transcription factors, cell-cycle associated factors, small molecules, extrinsic factors, and epigenetic 
factors via both extrinsic and intrinsic mechanisms. The positive regulators of self-renewal are indicated in green fonts, whereas 
negative regulators are shown in red fonts. TgF-b, transforming growth factor-b; Zfx, X-linked zinc-finger protein.
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capacity. Altogether these findings demonstrate the est
sential roles of epigenetic mechanisms in selftrenewal 
process which could possibly pave the way for developt
ing stem cell therapeutic interventions by exploiting 
PcG genes as potential target. 
Extrinsic pathway modulators-small molecules in self-
renewal
Systemically, stem cells are continuously influenced by 
extrinsic regulation from their hematopoietictinductive 
microenvironment or stemtcell niche in order to maint
tain primitive stem cells in the undifferentiated form. 
Certain key factors secreted by the bone marrow are 
suggested to have pivotal roles in regulating the quiest
cence of stem cells.28 However, the detailed mechanisms 
of the extrinsic modulators in the maintenance of the 
stem cell population remain elusive. For instance, osteot
blasts from the stem cell niche release the Tie2 ligand 
(angiopoietint1) to mediate quiescence in the stem cell 
pool. Similarly SDFt1 factor has also been secreted by 
endosteal cells in order to maintain the HSC pool.29 
Down regulation of BMPR1A, which is normally ext
pressed from osteoblasts, enhances the regenerative 
potential of HSCs. Signals from distal organs could 
also influence stem cell maintenance. For instance, dit
minished signaling from bone morphogenetic proteins 
in the ovary could lead to a decline in germ stem cells 
numbers thereby trigger ageing. Studies also confirm 
that the HSC pool can be linearly increased in act
cordance with the osteoblast population, suggesting 
that the niche plays an important role in maintaining 
a quiescent or primitive HSC population. Studies also 
indicate that the niche factors also influences mobilizat
tion, homing and engraftment of HSCs. For instance 
CXCL12, a cytokine expressed from bonetmarrow sit
nusoidal endothelial cells (BMECs), largely influences 
the mobilization, homing and engraftment of HSC.30
Several research groups have carried out chemical 
screening for small compounds that modulate selftret
newal in ES cells, neural stem cells and other adult stem 
cells. The underlying mechanisms by which certain 
small molecules regulate the selftrenewal in stem cells 
have been studied to characterize the molecular signat
tures of selftrenewal and to develop potential therapeut
tics. Retinoic acid, for instance, leads to alterations in 
HOX gene expression during embryogenesis and is a 
modifier of the WNTtmediated signaling pathway.31,32 
Prostaglandin E2 (PGE2), a small lipid mediator, has 
also recently been shown to regulate HSC selftrenewal 
during embryogenesis and can enhance HSC engraftt
ment, as measured by the competitive repopulation 
studies in mice.33 Selftrenewal can be augmented in stem 
cells with selftrenewal potential. HSCs can execute the 
selftrenewal programme, but the addition of WNT3A, 
sonic Hedgehog (SHH), and angiopoietintlike factors 
or PGE2 can increase the size of stemtcell pool. 
Stem cells under genotoxic stress/DNA damage
Protecting the genome integrity represents a fundat
mental and continuous challenge to stem cells comt
pared to their progenitors and differentiated cell types. 
Adult stem cells are susceptible to a variety of genotoxic 
stresses such as DNA damage and oxidative stress due 
to their inherent characteristics. First, given the fact that 
HSCs are maintained throughout the lifespan of an ort
ganism, a single HSC could accumulate multiple mutat
tions necessary for transformation. In other words, act
cumulating mutations are a potential concern not only 
to the selftrenewing stem cells, but also to either daught
ter cells or downstream progenitor lineages thereby 
largely compromising the genetic stability in multitude 
hierarchy levels. Secondly, stem cells share common feat
tures of tumor cells, i.e., a high proliferation potential 
that renders them susceptible to acquisition of multiple 
mutations. Thirdly, the relative quiescent nature of stem 
cells renders them resistant to chemotherapy and they 
are, therefore, a potential source of tumor recurrence. 
Cells have evolved multiple mechanisms, including sevt
eral DNA repair pathways, to remove DNA mismatcht
es and lesions and prevent the deleterious consequences 
of DNA damage. Under relative quiescence, with a low 
metabolic activity, stem cells could discourage genetic 
lesions induced by reactive oxygen species (ROS) which 
otherwise could contribute to DNA injury. Another 
protective mechanism of HSC comes from their bone 
marrow niche, which is predominantly hypoxic with 
low levels of oxidative stress. At the molecular level, 
stem cells efficiently efflux xenobiotic genotoxic comt
ponents through the ABC transporter system, which 
greatly reduces DNA damage. Another interesting 
mechanism by which stem cells might prevent erronet
ous genetic lesions could be attributed to asymmetric 
segregation of genetic information.34,35 Asymmetric cell 
divisions yield one daughter stem cell and one committ
ted progenitor cell. This intriguing mechanism allows 
a parent stem cell to segregate defective genetic infort
mation to a progenitor cell while passing the errortfree 
chromosomes to a daughter stem cell. This would tempt 
us to postulate that through asymmetric division stem 
cells not only preferentially retain the chromatids with 
‘active stemness’/stem celltspecific genes, but also retain 
the template without any replicative errors to maintain 
high fidelity in stem cell characteristics. However, the 
magnitude of the aforementioned protective mechat
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nisms against the genetic instability remains to be int
vestigated in detail. 
Although, accrual of mutations is regularly checked 
by tumor suppressor pathways in adult stem cells, cont
tinuous homeostatic demands inadvertently comprot
mise tumor suppressor mechanisms and profoundly 
challenge the genetic stability of stem cells. If DNA 
damage accumulation exceeds the levels of repair syst
tems or DNA damage response is deficient, unrepaired 
damages would propagate in the cells. Accumulating 
DNA lesions in stem cells could be cytotoxic and or cyt
tostatic leading to a large reduction in regenerative pot
tential and homeostatic maintenance as observed in an 
ageing phenotype. Alternatively, if lesions in stem cells 
are mutagenic, they could greatly contribute to carcit
nogenesis. At a given dose of radiation, adult stem cells 
and their immediate descendants are hypersusceptible 
to initiation of radiationtinduced apoptosis triggered 
by a DNA damage response. Indeed, this hypersuscept
tibility in stem cells is a testament to stringent cellular 
checkpoint programs available to protect the genome 
integrity. Failure to initiate apoptosis would be detrit
mental to the damaged tissue stem cells, as the flawed 
genome with prevalent mutations would descend to 
their progenitors in a higher magnitude.
DNA damagetinduced impairment in stem cell 
function leads to several clinical syndromes such as 
diminution in stem cell pools, generation of cancer 
stem cells inducing apoptosis or it causes differentiat
tion and bone marrow failure. Increased genetic instat
bility in LTtHSCs was shown to compromise the ret
constitution functionality.35 A recent report by Nijnik 
et al confirms that defects in DNA double strand 
break repair influence stem cell hematopoietic recont
stitution function.36 Furthermore, a number of DNA 
repair abnormalities are closely linked to premature 
aging syndromes with defects in the stem cell populat
tion. In most acute myeloid leukemia (AML), HSCs 
like cells such as CD34+CD38– phenotype cells are 
reported to have an intrinsic ability to initiate the leut
kemiagenesis.37 An interesting study by Graham et al 
has shown the presence of a significant quiescent (G0) 
population within the CD34+ population of hematot
poietic cells from patients with CML.38,39 In this case, 
an impaired DNA damage response observed in quit
escent HSCs could be explained by the fact that those 
HSCs under G0 phase (quiescent HSCs) are deficient 
in the homologous recombination repair pathway. A 
functional impairment in DNA damage repair is the 
ratetlimiting step for the maintenance of stem cells.36 
Accumulating genetic lesions could drive the ageing 
process.40 Although stem cells from aged mice with act
cumulating DNA mutations still could maintain the 
regenerative potential, their regenerative potential is 
severely compromised after injury.8,41 Together, these 
results are consistent with the view that DNA damt
age accumulates with ageing in the HSC compartment 
and that this damage can be physiologically significant 
if unrepaired. It is therefore how stem cells respond to 
genotoxic stress that is pivotal in understanding the 
underlying mechanisms of leukemiagenesis and aging. 
Nonhomologous endtjoining (NHEJ) and homolot
gous recombination (HR) are mechanistically distinct 
DNA repair pathways that ensure the repair of DNA 
doubletstrand breaks (DSBs). Failure of both NHEJ 
and HR pathways in HSCs could impact both funct
tion and proliferation efficiency.42
Stem cells in the ageing process
There is growing interest in the scientific understandt
ing of aging, as biological explanations are increasingly 
paradoxical to the extent that they are largely unknown 
despite extensive research. After all, mortality is the ult
timate destiny for any organism despite survival mecht
anisms at both the cellular and organism levels. Just as 
mortality is inevitabletageing is also inevitable. Our 
scientific understanding suggests that impaired tissue 
maintenance and repair are hallmarks of ageing, which 
is predominantly associated with an agetdependent 
decline in selftrenewal and the multitpotency potential 
of adult stem cell. Unraveling the molecular mechat
nisms that drive the stresstmediated decline in stem 
cell functionalities is pivotal to understand the ageing 
phenotype. Stem cell depletion due to the accumulat
tion of DNA damage has been reported in animals 
with genomic instability and has been implicated in the 
decline of tissue renewal capacity and the appearance 
of agingtrelated phenotypes.8,41 Stem cell depletion is 
a predominantly triggered cellular defense mechanism 
via stem cell senescence and/or apoptosis following 
DNA damage.43,44 The aging process is tightly driven 
by various mechanisms such as intrinsic, extrinsic and 
systemic factors. Such factors exhibit different levels of 
influence on the ageing process corresponding to the 
cell phenotype.45 In this, the impact of extrinsic factors 
can be exploited, at least in part to reverse the aging 
process, which was induced externally. For instance, a 
forced Notch signaling, through an extrinsic mechat
nism could rejuvenate agedtadult skeletal muscle 
cells.46 Further, this study demonstrates that TGFt
b/pSmad3 attenuation in old, injured muscle restores 
regeneration to satellite cells in vivo. However, HSCs 
also potentially accrue the aging characteristics with 
reduced selftrenewal and altered differentiation capact
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ity, indicating that intrinsic factors must be responsible 
for the reduced selftrenewal capacity. Here, the intrigut
ing possibility could be that the distinct aged HSCs 
phenotype as a result of their milieu, systemic factors 
or even intrinsic events might be manipulated to rescue 
some age disorders.
Generally telomere length, known as a molecular 
clock, defies chronological ageing to maintain the mort
tality of cells. Intrinsically, telomerase activity directly 
impacts the longevity of selftrenewing of primitive stem 
cells.47,48 The importance of the telomerase activity is 
illustrated by the fact that germinal cells with profound 
replicative efficiency in the ovaries and testis display an 
elevated level of telomerase activity.49 At the molecular 
level, low telomerase shortens the telomere to induce 
telomere dysfunction accompanied by profound DNA 
damage. This raises an interesting question how quiest
cent stem cells, despite their low telomerase expression 
maintain their longevity. Studies show that quiescent 
stem cells might enhance their TERT, a catalytic subt
unit of telomerase, thereby maintaining the telomeres 
and their cell replicative potential.50 
Telomere dysfunction activates a cascade of tumor 
suppressor mechanisms initiated by p16INK4a and ARF 
and thereby up regulates p53/Rb, causing senescence 
and apoptosis. This is exemplified by the fact that sigt
nificant up regulation of the senescencetassociated 
btgalactosidase and p16INK4a observed in ageing ort
ganisms. It is tempting to speculate that downtregulat
tion of p53 would enhance the selftrenewal of tissue 
stem cells and possibly their reconstitutive potential. 
However, studies show that down regulation of p53 
could rescue a stem cell defect, but inadvertently comt
promise tumortsuppressor activity, thus leading to a 
shorter lifespan with carcinogenesis.51 A striking balt
ance between selftrenewal and carcinogenesis could be 
attained if p21CIP instead of p53 is targeted to extend 
the stem cell longevity without leading to tumorigent
esis in telomeretdeficient mice.52
Given that behaviors of HSCs are stringently and 
coordinately regulated, it is inevitable that stress int
ducers from within and from their systemic milieu 
can frequently exacerbate their phenotypes. Besides, a 
recent study confirms that aged HSCs also contribute 
to the impaired stem cell function and engraft aged 
hematopoietic environment in telomere dysfunctional 
Terc_/_ mice.51 Stem cells regularly undergo stress durt
ing their lifetime and have evolved to deal with a vat
riety of stresses that diminish their potential. These 
stressors, including reactive oxygen species, acute or 
chronic DNA damage, telomere shortening,53,54 5tfluot
rouracil (5tFU), are proven to have an impact on tist
sue SC functionalities. Generally, chronic stress leads 
to decline in HSC number and the function of HSCs 
mediated by activation of the cell cycle inhibitor p21 
(Cdkn1a) accompanied by telomere shortening. As 
mentioned elsewhere, p53, p16Ink4A and FOXO are key 
to trigger physiologic stresstinduced stem cell aging 
thereby resulting in aged HSC phenotype.55t58 These 
stressors are proven as surrogate for human aging and 
agetassociated disorders. 
Adult stem cells receive influential ageing cues from 
environmental changes, as young HSCs into aged mit
croenvironment of telomerase wildttype mice also ret
sulted in reduced function of HSCs. Interestingly, cat
loric restriction not only leads to lifetspan extension in 
mice, but also ameliorates HSC ageing.59 Stem cells are 
typically characterized with enhanced levels of ABC 
multidrug transporter, Bclt2 and BcltxL and survivt
ing, which coherently defend the cytotoxic risk in the 
stem cell population.60 Collectively, these studies furt
ther emphasize the intricate interplay between multiple 
extrinsic and intrinsic factors and pathways governing 
the aging of HSCs. 
Stem cells and cancer
Accumulating evidence in recent years strongly indicates 
the existence of cancer stem cells in various solid tut
mors. A fascinating aspect is that cancer stem cells share 
many of the characteristics of normal stem cells, such 
as the ability to selftrenew and to give rise to multiple 
types of differentiated cells.61,62 In addition, some cancer 
stem cells might be direct descendants of normal tissue 
stem cells, indicating that normal stem cells can be the 
primary target of oncogenic transformation. Given that 
tumor initiation and progression require acquisition 
of multiple mutations during a long period, stem cells 
become a suitable target for the accumulation of mutat
tions and eventually malignant transformation.61 This 
has been largely attributed to the longevity of tissue 
stem cells, which makes stem cells prone to accrue more 
genomic alterations than their nontselftrenewing progt
eny, leading to stem cell genetic instability, an engine 
for neoplastic transformation and malignancy developt
ment.63 Although, any stem cell has a very rare probt
ability of acquiring chromosomal aberrations or being 
subjected to cancer risk formation, the consequences 
could be profound, as only a very few cancer cells are 
sufficient to trigger tumorigenesis.64 The cancer stem 
cells in the tumors not only initiate the tumor growth 
and sustain selftrenewal, but also maintain metastatic 
potential thereby challenging the conventional cancer 
therapies more vigorously than the normal cancer cells.
Arguably, one of the most striking and direct cont
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sequences of the genome instabilities is carcinogenesis. 
A hallmark of tumorigenesis is accumulation of genetic 
lesions in the cell cycle check points at a rate higher 
than in normal cells. Whereas the genome instabilities 
in tumors typically arise through states of continuous, 
sustaining, and perpetuating chromosomal mutations, 
irrespective of cytogenetic complexity or heterogenet
ity and genomic integrity per se. The cancer stem cell 
hypothesis has enormous implications for cancer therat
peutics.65 As current treatments targeting only rapidly 
proliferating cancer cells, a surviving small fraction of 
cancer stem cells might drive the secondary tumor ret
currence in cancer patients. Thus, identification and 
targeting of the cancer stem cells are of great clinical 
importance. 
Therapeutic implications of stem cells
It is apparent there are no simplistic chemotherapeut
tic approaches available for most debilitating disorders, 
such as degenerative disorders, cancers, and relevant tist
sue damage disorders. This roadblock in the treatment 
catalyzes enormous attention in the potential applicat
tions of stem cells. Due to their impressive selftrenewal 
and differentiation potentials, adult stem cells hold 
great promise in cell and gene therapy applications for 
the treatment of many disorders.66 Interestingly, tissue 
stem cells through their regenerative capability, are able 
to differentiate into residing tissue to partially restore 
the function. Mesenchymal stem cells from fetal bone 
marrow, for instance, are capable of differentiating into 
not only osteogenic, adipogenic and endothelial lineagt
es, but also hepatocytetlike cells, chondrocytes, muscles, 
neural, and erythroid cells.67 Interestingly, their regenert
ative and tissue repair potential are not restricted to their 
local milieu, but also to tissues of distal organs via prot
inflammatory cytokines and growth factors. The added 
benefit is that both autologous and allogenic stem cells 
have no immunoreactivity problems in systemic admint
istration and local transplantation, rendering stem cells 
as an ideal choice to deliver the genes of interest in gene 
therapy applications in various tissues. Development 
of celltspecific gene therapeutic approaches are now 
underway to cure various diseases including premature 
aging diseases, diabetes, atherosclerosis, hematopoietic, 
cardiovascular, musculoskeletal, gastrointestinal, pult
monary, urogenital, ocular, neurodegenerative and skin 
disorders.68
A recent study shows that retroviral coexpression 
of telomerase RNA component (TER) and telomerase 
reverse transcriptase (TERT), could extend telomere 
length and rescue autosomal dominant form of dyskert
atosis congenita cells from a phenotype characteristic of 
early senescence.69 The majority of human cancer cells 
overexpress hTERT but their level is subdued in nort
mal adult tissue70 rendering them an attractive target for 
tumor therapy. hTERT immunotherapy involves elicitt
ing cytotoxic Ttlymphocyte (CTL)tmediated immune 
response in most cancers patients. Gene therapy comt
prising of oncolytic adenoviral vector carrying apoptotic 
TNFtrelated apoptosistinducing ligand and E1A gene 
(Ad/TRAILtE1) may preferentially target CSCs71 and 
suppress tumor growth and survival. Similarly, many 
oncolytic adenoviral vector therapies have been aimed 
at treating breast, lung, prostate, pancreatic, and relt
evant cancers. Many potential therapeutic approaches 
were successfully developed by targeting genes involved 
in crucial stem cell pathways. For instance, Wnt, Notch, 
SCF, EGFR, Hedgehog, ILt4, Ras/MAPK, NFtkB 
and survivin signaling genes were targeted to eradicate 
resistance of cancer stem cells and also as adjuvants to 
conventional tumor therapeutics. Importantly, molecut
lar targeting of BMI1 using DNA methylation inhibitor 
5tazacytidine is able to control cancer stem cell growth.72 
Likewise, many Notch inhibitors, for instance,tsecret
tase inhibitors were developed for cancer therapy in 
leukemic patients.73 AntitWnt/btcatenin factors could 
destabilize the chronic lymphocytic leukemic cells74 by 
forcing them into enhanced apoptosis. Similarly, therapy 
aimed at targeted overexpression of Hes1 is sufficient to 
protect Mbs and melanocyte stem cells (MSCs) from a 
severe defect in hair pigmentation, followed by intensive 
hair graying.75 Many other therapeutic approaches, for 
instance, caloric restriction therapy supplemented with 
dietary natural compounds could maintain the longevity 
of the stem cells. Sirtuint1, for instance, is required for 
calorie restrictiontinduced lifespan extension in mice, 
and calorie restriction upregulates sirtuint1 in humans. 
Sirtuint1 also appears to influence lineage/celltfate decit
sions of stem cells via actively suppressing ROS levels to 
improve cell survival and cure type II diabetes mellitus 
like metabolic disorders.59
Conclusions and future directions
There has been tremendous progress in our understandt
ing of stem cells in the past few years. Unraveling the 
molecular mechanisms of adult stem cells is a prereqt
uisite to understand their causative roles in ageing, cant
cer and various degenerative disorders. Recent insights 
into the regulation of selftrenewal and differentiation of 
stem cells raise several fundamental questions. Besides, 
underlying mechanisms that dictate stem cell behavior 
and their implications in ageing and cancertlike disort
ders have not been established. In addition, how the 
bone marrow niche regulate the fate of stem cells and 
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how stem cells respond to their signals remain to be ant
swered. It is also intriguing to know how an organism 
drives the stem cell mobilization and their reestablisht
ment at distal tissue organs in response to variety of 
stressors. The prevalence of complex degenerative dist
orders propagates our immense interest in development 
of novel therapeutic approaches against these disorders. 
Hightthroughput, multifaceted, and sophisticated apt
proaches should be directed to gain more insights into 
the complex defense mechanisms of rare populations 
of cancer stem cells, which protect them against cont
ventional therapies. In particular, by exploring semit
nal aspects of stem cells, the mosttpromising targeted 
therapies for various chronic degenerative disorders can 
be designed. 
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